Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Brain Res ; 1763: 147448, 2021 07 15.
Artículo en Inglés | MEDLINE | ID: mdl-33771519

RESUMEN

BACKGROUND: Sex hormones have been implicated in pH regulation of numerous physiological systems. One consistent factor of these studies is the sodium-hydrogen exchanger 1 (NHE1). NHE1 has been associated with pH homeostasis at epithelial barriers. Hormone fluctuations have been implicated in protection and risk for breaches in blood brain barrier (BBB)/blood endothelial barrier (BEB) integrity. Few studies, however, have investigated BBB/BEB integrity in neurological disorders in the context of sex-hormone regulation of pH homeostasis. METHODS//RESULTS: Physiologically relevant concentrations of 17-ß-estradiol (E2, 294 pM), progesterone (P, 100 nM), and testosterone (T,3.12 nM) were independently applied to cultured immortalized bEnd.3 brain endothelial cells to study the BEB. Individual gonadal hormones showed preferential effects on extracellular pH (E2), 14C-sucrose uptake (T), stimulated paracellular breaches (P) with dependence on functional NHE1 expression without impacting transendothelial resistance (TEER) or total protein expression. While total NHE1 expression was not changed as determined via whole cell lysate and subcellular fractionation experiment, biotinylation of NHE1 for surface membrane expression showed E2 reduced functional expression. Quantitative proteomic analysis revealed divergent effects of 17-ß-estradiol and testosterone on changes in protein abundance in bEnd.3 endothelial cells as compared to untreated controls. CONCLUSIONS: These data suggest that circulating levels of sex hormones may independently control BEB integrity by 1) regulating pH homeostasis through NHE1 functional expression and 2) modifying the endothelial proteome.


Asunto(s)
Barrera Hematoencefálica/metabolismo , Estradiol/fisiología , Progesterona/fisiología , Intercambiador 1 de Sodio-Hidrógeno/metabolismo , Testosterona/fisiología , Animales , Transporte Biológico , Células Endoteliales/metabolismo , Estradiol/sangre , Concentración de Iones de Hidrógeno , Progesterona/sangre , Proteoma/metabolismo , Ratas , Testosterona/sangre
2.
PLoS One ; 15(5): e0227463, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32469979

RESUMEN

Disruption of blood-brain barrier integrity and dramatic failure of brain ion homeostasis including fluctuations of pH occurs during cortical spreading depression (CSD) events associated with several neurological disorders, including migraine with aura, traumatic brain injury and stroke. NHE1 is the primary regulator of pH in the central nervous system. The goal of the current study was to investigate the role of sodium-hydrogen exchanger type 1 (NHE1) in blood brain barrier (BBB) integrity during CSD events and the contributions of this antiporter on xenobiotic uptake. Using immortalized cell lines, pharmacologic inhibition and genetic knockdown of NHE1 mitigated the paracellular uptake of radiolabeled sucrose implicating functional NHE1 in BBB maintenance. In contrast, loss of functional NHE1 in endothelial cells facilitated uptake of the anti-migraine therapeutic, sumatriptan. In female rats, cortical KCl but not aCSF selectively reduced total expression of NHE1 in cortex and PAG but increased expression in trigeminal ganglia; no changes were seen in trigeminal nucleus caudalis. Thus, in vitro observations may have a significance in vivo to increase brain sumatriptan levels. Pharmacological inhibition of NHE1 prior to cortical manipulations enhanced the efficacy of sumatriptan at early time-points but induced facial sensitivity alone. Overall, our results suggest that dysregulation of NHE1 contributes to breaches in BBB integrity, drug penetrance, and the behavioral sensitivity to the antimigraine agent, sumatriptan.


Asunto(s)
Barrera Hematoencefálica/metabolismo , Depresión de Propagación Cortical/genética , Intercambiador 1 de Sodio-Hidrógeno/genética , Sumatriptán/farmacología , Animales , Encéfalo/efectos de los fármacos , Encéfalo/patología , Sistema Nervioso Central/efectos de los fármacos , Sistema Nervioso Central/patología , Depresión de Propagación Cortical/efectos de los fármacos , Modelos Animales de Enfermedad , Células Endoteliales/efectos de los fármacos , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Inyecciones Intraperitoneales , Migraña con Aura/tratamiento farmacológico , Migraña con Aura/genética , Migraña con Aura/patología , Ratas , Intercambiador 1 de Sodio-Hidrógeno/antagonistas & inhibidores , Ganglio del Trigémino/efectos de los fármacos , Ganglio del Trigémino/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA